BioReference Laboratories competitors

K Newton are a Board Member at MIMEDX GROUP, INC.; Senior VP/CFO/COO at ARTHROCARE CORPORATION; and Chief Executive Officer at APOLLO ENDOSURGERY, INC.. They have worked as President/CEO at Synenco Energy Inc, Exec VP/CFO at Synenco Energy Inc, and Board Member at Synenco Energy Inc. K work or have worked as MEMBER at Minnesota State Society of CPAs, MEMBER at Texas State Society of Certified Public Accountants, and MEMBER at American Inst of Certified Public Accountants. They studied at UTSA - The University of Texas at San Antonio.

Mr. Schechter has served as a director of the Company since April 1, 2013. Mr. Schechter is an Executive Vice President of Merck & Co., Inc. and since 2010 has been President of Merck’s Global Human Health Division, which includes the company’s worldwide pharmaceutical and vaccine businesses. He is a member of Merck’s executive committee and pharmaceutical and vaccines operating committee. Prior to becoming President, Global Human Health, Mr. Schechter served as President, Global Pharmaceutical Business from 2007 to 2010. Mr. Schechter’s extensive experience at Merck includes global and U.S.-focused leadership roles spanning sales, marketing, and managed markets, as well as business and product development. Mr. Schechter serves on the Board of Directors for the European Federation of Pharmaceutical Industries and Associations. He is a Board Member for Water.org and an Executive Board Member for the National Alliance for Hispanic Health.

Steve Rusckowski is Chairman, President and Chief Executive Officer of Quest Diagnostics. Since joining Quest Diagnostics as President and Chief Executive Officer in May 2012, Mr. Rusckowski has focused on transforming the company, based on its compelling vision of “Empowering better health with diagnostic insights.” Under his leadership, the company has refocused on its core diagnostic information services business, sold non-core assets, delivered disciplined deployment, including share repurchases and acquisitions, and simplified its organizational structure to better serve customers by removing complexity, speeding decision making and empowering employees. He was elected Chairman of the Board in December 2016. Prior to joining Quest Diagnostics, Mr. Rusckowski was CEO of Philips Healthcare, which became the largest unit of Royal Philips Electronics under his leadership. He joined Philips in 2001 when it acquired the Healthcare Solutions Group he was leading at Hewlett-Packard/Agilent Technologies. Mr. Rusckowski is a member of the Board of Directors of Project Hope, a global health education and humanitarian assistance organization. He is also a member of the Board of Directors of the American Clinical Laboratory Association, and served as its Chairman from 2014 to 2017. Mr. Rusckowski earned a Master of Science degree in Management from the Massachusetts Institute of Technology’s Sloan School of Management and a Bachelor of Science degree in Mechanical Engineering from Worcester Polytechnic Institute.

Cheryl Vance is a President/CEO at Alverno Provena Hospital Laboratories Inc and President/CEO at Alverno Clinical Laboratories LLC. She has worked as President/CEO at MedCentre Laboratories. Cheryl studied at Nebraska Wesleyan University between 1965 and 1966 and Central Michigan University until 1985.

Healthcare business executive with broad experience in product development, global marketing, commercialization and sales of medical devices. Strong background in market analysis, reimbursement strategy, regulatory and clinical affairs, new product development, sales force optimization and domestic and international product commercialization. Specialty experience working with medical societies, patient advocacy groups, governmental agencies, public and private insurance companies, investor relations, capital funding, business development and strategy development including strategic planning and acquisitions.

Mr. James E. Fantus is a President and Chief Executive Officer at CLINICAL LABORATORY PARTNERS and is based in United States.

John Armitage is a CEO at Oklahoma Blood Institute, President at Global Blood Fund, and Manager at ALLIANCE FOR COMMUNITY TRANSFUSION SERVICES LLC and is based in London, Oklahoma City, Oklahoma. He has worked as Exec Director at New Jersey Blood Services, CEO and Medical Director at Appalachian Region - Am Red Cross, and CEO at Greater Alleghenies Region - Am Red Cross. John studied at Duke University School of Medicine, Yale, and North Carolina School of Science & Mathematics.

Ms. Jacqueline Eastwood is a Founder, President and Chief Executive Officer at Salient Surgical Technologies and is based in United States.